Major pharmaceutical company Novo Nordisk now tells its 60,000 suppliers that they must both produce and transport their products 100 percent sustainably from 2030. Otherwise they will lose Novo Nordisk as customer.
Denmark's position in the world market for peptide-based pharmaceutical development now causes a British biotech firm to relocate its entire management and development lab to the country. The goal is effective growth, and the firm has already made a deal with a top-ten pharma company.
The Danish regions plan to save DKK 1bn (USD 159m) in the goods and services area before 2025. That's the ambition the Regions Joint Procurement announced in a new procurement strategy. It will be realized by optimizing tenders, by using new digital solutions and by purchasing jointly.
The declining amount of new antibiotics against multi-resistant bacteria has caused the Swedish government to test an alternative pricing model for procuring antibiotics, and this has brought three new products onto the Swedish market. The industry calls for similar models in other countries.
The life science and biotech industries can generate up to 18,000 new jobs and boost GDP with DKK 150bn and the tax revenue by DKK 55bn, according to Novo Nordisk, who is in charge of the government's life science and biotech financial recovery team.
Thomas Cueni, director general at the global trade association IFPMA uses the word "grim" to describe the antibacterial pipeline currently under clinical development. He hopes this picture can be changed through the newly established antibiotics fund, AMR Action Fund.
16 years ago, it started out with a good idea, and now parallel import company Abacus Medicine has reached 1,000 employees. The journey has sometimes been hard, but CEO and founder Flemming Wagner knew it would be a great adventure from the get-go, he says.
The office and lab space Copenhagen Bio Science Park (Cobis) is growing through the roof and renting offices in adjacent buildings owned by Rigshospitalet to meet the massive demand from biotech firms, which keeps rising in spite of Covid-19.
New kid on the block Audientes does not see itself as a competitor to established players on the hearing aid market and does not worry about being run over by tech giants like Apple. "There's an incredible gap on the market, and that's where our focus is," the CEO states.
New study results for Meabco's treatment against radiation damage has generated so much attention from collaborative partners in the US government that the latter now intends to expand the deal with the Danish biotech company.
Antibiotic resistant bacteria can be defeated using newly developed antibiotics. Yet people are dying in the thousands every year because of resistant infections. The reason behind this is an incoherent market, say people from the industry.
Astrazeneca Chief Executive Officer Pascal Soriot said the coronavirus vaccine the company is developing with the University of Oxford could still be ready before the end of the year after pausing its trials due to a possible serious neurological problem in one patient.
Companies are once again calling for their employees to work from home, after Danish health minister Magnus Heunicke on Monday encouraged people to work remote in Odense and the Copenhagen Metropolitan Area.
Nordic Bioscience Chairman Claus Christiansen and the families behind hearing aid company Widex have joined the owner group of a new Danish biotech firm, which has its eyes set on success with its new pharmaceutical hope for patients with osteoarthritis in the knee. "We view this as a very exciting and attractive investment".
The world longs for a vaccine to end the Covid-19 pandemic, but the solution isn't that simple and unrealistic hopes have serious consequences, says MSD Managing Director for Denmark and Iceland Andreas Daugaard Jørgensen.
Friday last week, Danish firm Drugstars launched a new global service, which collects medicine users' experiences from thousands of drugs. This will give the pharmaceutical industry a whole new insight into how patients think about their products, explains CEO Founder Claus Møldrup.
Changes are underway at Leo Innovation Lab, which will be acting as a digital venture fund to a higher extent than before at the same time as the laboratory hatches tomorrow's solutions within digital dermatology.
The Danish Cancer Society takes the lead in a joint complaint from Europe's cancer associations to the EU and the pharmaceutical industry to ensure "fairer and more transparent" cancer medicine prices. Otherwise, people won't be able to afford medicine in the future, it states.